A test bed for production of biological products.
PharmTech.com made an interview with Jesper to learn about the Testa Center, the effects of the pandemic, and the future. Felicity Thomas summarized the best parts in this three-minute article. About the Testa Center After Jesper had introduced Testa Center as “In the Testa Center, researchers have access to both equipment and expertise to drive …
Continue reading “Jesper on Testa Center, the pandemic and the future”
European start-ups invited to take advantage of the unique pilot-scale testbed for biological drugs. The Testa Center is a purpose-built bioprocessing testbed with modern upscaling equipment open to anyone wishing to verify their latest technology or scale up their processes. In a new initiative “Testa Center outreach” the center is reaching out beyond the Nordics …
During December 2020, final-year students from Uppsala university learned all about bioprocess optimization for cell growth and purification, and what life is like when you are employed at a bioprocess company. All the students were from Uppsala University’s Master’s program in Molecular Biotechnology Engineering. This project is the main topic for their last course of …
Learn about the capabilities and benefits available to your project in the Testa Center. This video is an 26 minutes introduction by Jesper Hedberg, director of the Testa Center. Moderated by Anton Ussi, Operations & Finance Director for EATRIS C&S. Agenda 0:00 Introduction by Anton Ussi 2:45 Presentation by Jesper Hedberg 9:40 Capabilities 14:21 The …
It was now day five – the last day of the Testa Challenge 2020. Not even such an intense week could bring down the energy levels of the Testa Challenge participants. Ambition, passion and drive are something these participants brought in abundance. So much that when the time came, no one really wanted to leave! …
Continue reading “Day 5: Is it over, or just the start of something new?”
Biopharma trends in 2020 are; The development of novel personalized therapies. The ever increasing costs for the next generation of biologics. New technology in biopharma benefits the process development, quality by design and standardization. Companies are adapting to “fail fast and fail cheap”-methods be become more efficient. Given these trends, can you please describe your …
Continue reading “Day 4: Strategies on how to be successful in biopharma”
They call Wednesday a hump day for a reason. After day one and day two pushing the teams to their limits, the learning curve was certainly step. But at the Testa Center we keep on pushing, and things started to look more downhill. Due to the unforeseen circumstances from day two, day three was committed …
Day two was when many of the participant’s experiments were going live; Video analysis detection, live process-data streaming from Sweden to the US, in-bag sensors to retrieve data from the bioreactor and in-parallel flask ShakeReactors replicating the bioprocess in small-scale. Everything went according to plan, until we had to reset and start it all over …
Like most systematic approaches, a failing cog, loose wiring or a single broken piece can cause the whole process to come to a halt. The same principle applies to bioprocess manufacturing. Thinking ahead and preparing for many months in advance, we have put several mitigations in place to keep the process going throughout the Testa …
Continue reading “Day 1: Don’t try this at home, or in GMP (try it at the Testa Challenge!)”
Why is it hard for tech and digital innovation companies to brake new ground in the bioprocess market? Proprietary data standards, long product cycles, legacy systems, high investment costs and an intellectual property mine field are just a few of the obstacles for the startups, small and medium enterprises and industry. Testa Center is committed to …
Continue reading “Solving the chicken-and-egg problem with technology in bioprocess”
The Testa Challenge application period closed in the end of August 2020. ArgusEye and Unibap are two out of the six companies who where selected to participate. At Innovationsveckan you learn why ArgusEye and Unibap participates in the Testa Challenge. Why did they apply and what they plan to do in the Testa Challenge?! See …
Continue reading “Learn why ArgusEye and Unibap participates in Testa Challenge”
After a comprehensive selection phase, we are proud to present this year’s Testa Challenge participants. ArgusEye, atSpiro, Freesense, IS-Instruments, Scitara and Unibap are companies from around the world who have been selected to integrate their innovation into the bio-processing workflow to address the areas of efficiency, sustainability and control. More about each and everyone of …
Continue reading “These are the Testa Challenge participants”
A test bed to grow the life science and bio-process industry, that was what Lotta Ljungqvist, Emmanuel Ligner, Mikael Damberg and Jesper Hedberg was thinking of back in 2016. Today, after two years in business and many successful projects, Testa Center is delivering on its promise! Strategy In the beginning of 2016, Mikael Damberg, at …
Continue reading “Two years with successful projects in Testa Center”
Cytiva to test products in a realistic environment very similar to that of our customers. “We ran an entire process from start to finish and were given the opportunity to test everything in large scale”
Remote work and training has ramped-up as Covid-19 have made it much harder for anyone to travel. During this week we conduced several days of training over the Internet. In this video Andreas hit the emergency stop for the purposes of training. It was easy to see the benefits of not having to travel, staying …
Continue reading “Remote training on the Xcellerex Disposable Reactor”
In May, we had a training on how to leverage parallel bio-reactors. Ramcon‘s two experts, Kenneth Rasmussen and Ida Järbur came to Testa Center and gave a training session on the Lucullus software (from Securecell). The software is used to program and control our Applikon Ez-2 parallel bio-reactors, but can be used for a wide …
Continue reading “Training how to leverage parallel bio-reactors”
Testa Challenge has now closed for applications. We are happy to announce that we have received very exciting, innovative proposals including sensors, smart laboratory tools, digital twins, process modelling, automation, process control, sampling systems and more! We are very pleased to have attracted both Swedish as well as international proposals, from countries such as US, …
Continue reading “Testa Challenge application period is over”
Cytiva press release (in Swedish) today on the work to test approximately ~1500 people for Covid. Read more about how Testa Center is contributing by sample preparation and logistics. “Cytiva bidrar med kunskap och resurser för utveckling av logistik och provhantering. Lotta Ljungqvist, VD Testa Center, Cytiva, säger: ”Vi kom ifråga eftersom vi har kapacitet …
we will open our laboratories this fall for a week, both for academic and commercial innovators in the technical or digital field who would have the potential to increase the efficiency or quality of a bioprocess workflow.
We welcome all kind of innovative solutions that have the potential to meet the future technology needs within bio-production. Some examples in the area of technology include sensors, separation technology, pumps, etc. and within the digital/data segment, some examples include cloud solutions, VR / AR, AI, data transfer, modeling, automation, smart laboratory tools, etc.
Projects and companies from the technology/digital segments are invited to integrate, test and witness their innovation within a sponsored production workflow at Testa Center. Alongside the production process, participants will be supported by experts and have the possibility to experience their innovation hands on.
We are happy to announce that Testa Center is now part of Cytiva. We continue our operations as always, and are looking forward to working with you and our community of best-in-class companies in Life Sciences, Diagnostics and Environmental & Applied Solutions.
As the situation around COVID-19 progresses, we endeavor to keep our Testa Center offices and labs open at this time for important scientific work. We are working daily with our Crisis Response Teams to coordinate our efforts as a global company to find a balance between producing the critical medical equipment our customers need with …
Continue reading “Testa Center precautions and policies – COVID-19”
Protein Science Facility, offer services in protein production and provides access to infrastructure for Macromolecular X-ray crystallography (MX) and biophysical protein characterization. Their staff, Tomas Nyman, Elin Dunevall, Henry Ampah-Korsah, Emilia Strandback and Martin Moche all made the trip from Biomedicum and the department of Medical Biochemistry and Biophysics at Karolinska Institutet to learn more …
Continue reading “Protein Science Facility visits Testa Center”
One in five children does not have access to the most basic vaccines, and every year approximately 1.5 million people die from diseases that could be prevented with the help of vaccines. A major reason for this situation is the difficulty in getting vaccines to those who need them most: It is incredibly difficult to …
Continue reading “Ziccum – A Small Company with a Big Vision”
The spider web’s strength and elasticity make it a fantastic material with many desirable properties. It is made up of proteins, which make it useful for repairing damaged tissue in the body. For example, it is known that the cardiac musculature is often destroyed during a heart attack. Spider silk can, in this case, be …
Maximum funding per project: 300 000 SEK
Required co-funding: 50% (for all entities, including universities).
Who can apply? The opening is available for academic researchers, SME and large companies.
How to apply? Proposals are welcome and will be evaluated on a continual basis. Please contact helena.stroberg@uppsalabio.com or kristin.hellman@uppsalabio.com
Sara Mangsbo and her research group just now spend their last month at Testa Center. In pursuit of new cancer therapies, they have tried to create a stable cell line that will hold protein production on a larger scale. The time spent at Testa Center has been valuable and has provided new insights about what …
On the 11th of December we had the pleasure to welcome Felix Langkjaer, Martin Ohlsson, Peter Cullen with entourage, from Rockwell Automaton, for a meeting in Testa Center. Rockwell Automation an supplier of automation in a broad spectrum of industries. Testa Center is a flexible and open access bio-process R&D facility. Mixing these two in …
Continue reading “Rockwell Automation in Testa Center for Pharma 4.0”
Testa Center went to Finland in November to visit PharmaCity, BioCity, Slush and Y-science to meet and greet with Life Science companies. Although we did not see the sun for four days, it felt like a bright light was shining on us due to the many inspiring people we met! Prohealth Accelerator in Åbo/Turku At …
Continue reading “An inspiring Life Science visit to Finland in November!”
How do you work with ideas and innovation in Healthcare and Life Sciences? Region Uppsala Innovation came to Testa Center to discuss open healthcare environments for innovation projects. There seems to be a lot of similarities in the concept to the “test bed”-concept by which Testa Center opens up Life Sciences for academia, companies and …
Academia, startups, companies and industry are all welcome to Testa Center – an open, non-profit, non-GMP, production-like facility and test-bed for education, innovation and proof-of-concept experiments on production processes for biological products. e.g. monoclonal antibodies, peptides and proteins. Access both equipment and expertise to go from lab bench scale to industrial scale of protein production …
“Fifteen projects from Scandinavia have so far benefited from the technology and know-how available at Testa Center. Read full text Over the year we have had the pleasure to have a great variety of project in Testa Center! “The projects range from scale-up and purification activities, educational programs, and digital verification to GE Healthcare Life …
Continue reading “Press release “A successful first year for Testa Center””
Come and celebrate one year of great work with our customers and the Testa Center team. Welcome to celebrate the first year anniversary at Testa Center! Meet the testa team, representatives from the first year performing companies and people from the Life Science industry. First we give you some high-lights from the year, what is …
Continue reading “One year anniversary the 26th of September!”
Want to meet Testa Center’s staff and discuss projects, instruments, innovation-hubs or similar? We are happy see you and welcome you to visit us in stand #20. Looking forward to see you at Nordic Life Science Days 2019! Dr. Lotta Ljungqvist, Testa Center CEO, holds the Official Opening Plenary Make sure to see and listen …
Continue reading “See Testa Center in stand #20 at Nordic Life Science Days 2019!”
Uppsala innovation day is a half-day conference on innovation. We expect a lot of networking and forward looking on new companies, technology and trends in science. Testa Center will be present together with Uppsala BIO and have a selfie-booth where you can try out lab-coats and protective-glasses which are used in our labs! Come by …
We are very proud to announce that Lotta Ljungqvist, President & CEO GE Nordics & CEO Testa Center at GE Healthcare received the Biotech Builders’ Award for 2019. According to Biotech Builders, the winner of the prestigious award is a person who embodies the entrepreneurial fundamentals, laying way for the future of the Swedish Life …
Continue reading “Lotta Ljungqvist receives the prestigious Biotech Builders’ 2019 Award”
The Gothenburg based, Swedish biotech company Toleranzia AB entered Testa Center building in Uppsala with packages full of materials and hope. Their entrance represents an important national breakthrough for and an opportunity for Toleranzia to validate the manufacturing process for the drug candidate TOL2 and to provide further industrialization of the company itself. “I think …
Manufacturing proteins to support turning cells into any organ of the human body may seem like a movie scene, but BioLamina, a flourishing Swedish company makes it seem more real. Dedication, knowledge and the right environment are the necessary tools to achieve the goal of scaling up and growth. With that in mind, the team …
The Finnish company Sciar Company ltd. creates software for Augmented Reality (AR) and Mixed Reality (MR) to take human errors out of the equation in Life Science laboratories. Testa Center, as a bridge between innovation, science and industry, could contribute to the development of their product. SciAR has a primary position twice: as a first …
Continue reading “Testa Center welcomes the SciAR Company to test AR/MR in Bio-process labs”
In an announcement on February 25, GE announced the proposed sale of parts of the current Life Sciences business to US-based Danaher Corporation. The transaction, is subject to customary closing conditions, including regulatory reviews and appropriate consultation processes, and is expected to be complete by 4Q 2019. Testa Center, as a non-profit company owned and operated by …
Continue reading “GE to sell Bio-Pharma Business to Danaher”
The long-term collaboration agreement with Uppsala University and GE Healthcare gives not only researchers, but also students access to the equipment and specialized expertise at Testa Center. Now in December we are thrilled to have the first class of last-year students on the Master of Science programme in Molecular Biotechnology Engineering at Uppsala University at …
Continue reading “Uppsala University Master’s Students at Testa Center”
The Swedish biotechnology company BioLamina was the first customer to run their project at Testa Center. BioLamina was founded in 2008 by Dr. Karl Tryggvason and his son Dr. Kristian Tryggvason, and today the company has grown into a business with global presence and about 20 employees. BioLamina develops, manufactures and distributes premium cell culture …
Continue reading “BioLamina first to arrive to Testa Center”
Uppsala-based start-up company Ilya Pharma was among the vert first customers to run their project at Testa Center and to use its bio-process equipment. Ilya Pharma was founded in 2016 based on ground-breaking research from Uppsala University and Swedish University of Agricultural Sciences (SLU) and has today grown to a team of 15 people. The …